1. Home
  2. FLS vs RGEN Comparison

FLS vs RGEN Comparison

Compare FLS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLS
  • RGEN
  • Stock Information
  • Founded
  • FLS 1790
  • RGEN 1981
  • Country
  • FLS United States
  • RGEN United States
  • Employees
  • FLS N/A
  • RGEN N/A
  • Industry
  • FLS Fluid Controls
  • RGEN Medical/Dental Instruments
  • Sector
  • FLS Industrials
  • RGEN Health Care
  • Exchange
  • FLS Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • FLS 7.1B
  • RGEN 6.5B
  • IPO Year
  • FLS N/A
  • RGEN N/A
  • Fundamental
  • Price
  • FLS $56.26
  • RGEN $119.75
  • Analyst Decision
  • FLS Strong Buy
  • RGEN Buy
  • Analyst Count
  • FLS 9
  • RGEN 10
  • Target Price
  • FLS $66.89
  • RGEN $163.78
  • AVG Volume (30 Days)
  • FLS 1.6M
  • RGEN 706.1K
  • Earning Date
  • FLS 10-27-2025
  • RGEN 11-11-2025
  • Dividend Yield
  • FLS 1.50%
  • RGEN N/A
  • EPS Growth
  • FLS 13.91
  • RGEN N/A
  • EPS
  • FLS 2.21
  • RGEN N/A
  • Revenue
  • FLS $4,646,070,000.00
  • RGEN $673,956,000.00
  • Revenue This Year
  • FLS $6.59
  • RGEN $16.74
  • Revenue Next Year
  • FLS $4.10
  • RGEN $13.86
  • P/E Ratio
  • FLS $25.28
  • RGEN N/A
  • Revenue Growth
  • FLS 3.15
  • RGEN 8.73
  • 52 Week Low
  • FLS $37.34
  • RGEN $102.97
  • 52 Week High
  • FLS $65.08
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • FLS 52.49
  • RGEN 50.04
  • Support Level
  • FLS N/A
  • RGEN $112.73
  • Resistance Level
  • FLS $57.57
  • RGEN $122.71
  • Average True Range (ATR)
  • FLS 1.01
  • RGEN 4.63
  • MACD
  • FLS -1.85
  • RGEN -0.46
  • Stochastic Oscillator
  • FLS 97.72
  • RGEN 55.87

About FLS Flowserve Corporation

Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. It has three business segments: FPD for custom engineered pumps, pre-configured industrial pumps, pump systems, mechanical seals, auxiliary systems and replacement parts and related services; and FCD for engineered-to-order and configured-to-order isolation values, control valves, valve automation products and related equipment and Eliminations and All Other.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: